These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 17654664)

  • 1. Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy.
    Wright JD; Grigsby PW; Brooks R; Powell MA; Gibb RK; Gao F; Rader JS; Mutch DG
    Cancer; 2007 Sep; 110(6):1281-6. PubMed ID: 17654664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
    Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
    Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How important is removal of the parametrium at surgery for carcinoma of the cervix?
    Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
    Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.
    Stegeman M; Louwen M; van der Velden J; ten Kate FJ; den Bakker MA; Burger CW; Ansink AC
    Gynecol Oncol; 2007 May; 105(2):475-80. PubMed ID: 17292460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
    Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
    Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cervical cancer and parametrial involvement: is it significant?
    Steed H; Capstick V; Schepansky A; Honore L; Hiltz M; Faught W
    Gynecol Oncol; 2006 Oct; 103(1):53-7. PubMed ID: 16516279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is radical surgery (or parametrectomy) needed in all surgical procedure for early stage cervical cancer?].
    Uzan C; Gouy S; Pautier P; Lhommé C; Duvillard P; Haie-Meder C; Morice P
    Gynecol Obstet Fertil; 2009 Jun; 37(6):504-9. PubMed ID: 19467906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of lymphovascular space invasion and risk of pelvic lymph node metastases in stage IB1 cervical cancer.
    Chandacham A; Charoenkwan K; Siriaunkgul S; Srisomboon J; Suprasert P; Phongnarisorn C; Cheewakraingkrai C; Siriaree S; Tantipalakorn C; Kietpeerakool C
    J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S31-6. PubMed ID: 17722314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?
    Kamelle SA; Rutledge TL; Tillmanns TD; Gould NS; Cohn DE; Wright J; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
    Gynecol Oncol; 2004 Aug; 94(2):249-55. PubMed ID: 15297159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
    Wright JD; Grigsby PW; Rader JS; Mutch DG; Powell MA; Gao F; Gibb RK
    Gynecol Oncol; 2007 Nov; 107(2):280-4. PubMed ID: 17698175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
    Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
    Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors that affect survival after the treatment of early stage cervical carcinoma.
    Atasii T; Aksu MF; Cetinkaya MB
    Int Surg; 2000; 85(2):147-51. PubMed ID: 11071333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.